Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Dow
Boehringer Ingelheim
AstraZeneca
Mallinckrodt

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

Asparaginase - Biologic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Recent Clinical Trials for asparaginase

Identify potential brand extensions & biosimilar entrants

SponsorPhase
CalciMedica, Inc.Phase 1/Phase 2
Jazz PharmaceuticalsPhase 2/Phase 3
PETHEMA FoundationN/A

See all asparaginase clinical trials

Recent Litigation for asparaginase

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Genentech, Inc. v. Pfizer Inc.2019-04-05
Genentech, Inc. v. Immunex Rhode Island Corp.2019-03-29
Genentech, Inc. v. Amgen, Inc.2017-10-18

See all asparaginase litigation

PTAB Litigation
PetitionerDate
Hospira, Inc.2016-09-09

See all asparaginase litigation

Patent Text Search: US Patents for asparaginase

These patents were identified by searching patent claims

Supplementary Protection Certificates for asparaginase

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00267 Netherlands   Start Trial PRODUCT NAME: PERFLUTREN BEVATTENDE LIPIDE-MICROBOLLEN; REGISTRATION NO/DATE: EU/1/06/361/001 20060920
35/1996 Austria   Start Trial PRODUCT NAME: PEGYLIERTES LIPOSOMALES DOXORUBICIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES
90017-8 Sweden   Start Trial PRODUCT NAME: LIPIDMIKROSFAERER INNEHALLANDE PERFLUTREN; REG. NO/DATE: EU/1/06/361/001 20060920
0267 Netherlands   Start Trial PRODUCT NAME: PERFLUTREN BEVATTENDE LIPIDE-MICROBOLLEN; REGISTRATION NO/DATE: EU/1/06/361/001 20060920
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Mallinckrodt
Harvard Business School
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.